Novo Holdings to buy Altasciences from Audax Private Equity

Novo Holdings has agreed to acquire Altasciences, a Laval, Quebec-based drug development services provider to pharmaceutical and biotechnology companies.

ByIris Dorbian

23 February 2021•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Canada North America US Healthcare Briefs

Novo Holdings to buy Altasciences from Audax Private Equity

Audax Group

Harris Williams

Novo Holdings A/S

Related articles